CompletedPhase 3

BOTOX® in the Treatment of Upper Facial Lines in Japan

Japan101 participantsStarted 2013-02

Plain-language summary

This study will evaluate the safety and efficacy of BOTOX® (botulinum toxin Type A) for the treatment of upper facial lines (Crow's Feet Lines and Frown Lines).

Who can participate

Age range20 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓Moderate to severe Crow's Feet Lines and Frown Lines

What they're measuring

Percentage of Participants Achieving None or Mild on the Investigator's Assessment of the Severity of Crow's Feet Lines (CFL) at Maximum Smile Using the Facial Wrinkle Scale-Asian (FWS-A)

Timeframe: Day 30

Trial details

NCT IDNCT01797094

SponsorAllergan

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2013-07

Results submitted2015-01-27

View on ClinicalTrials.gov More Upper Facial Rhytides trials